Loading organizations...
§ Venture Capital
Institute of Pathology and Genetics, a non-profit providing expertise for diagnostics and treatments in pathology, genetics, and advanced.
IPG/bio.be, the Institute of Pathology and Genetics, is a non-profit organization based in Charleroi, Belgium, focused on advancing medical diagnostics and treatments through pathology and genetics expertise. The institute delivers innovative diagnostic services and specialized genetic analyses, aiding healthcare professionals and researchers in understanding diverse medical conditions. Its mission centers on applying scientific knowledge to improve patient care and develop personalized medicine strategies within the Belgian medical sector. Operating as a non-profit association, IPG/bio.be prioritizes public health initiatives and collaborative research to enhance diagnostic capabilities. Specific operational metrics, such as employee count or user base, and key partnerships are not publicly disclosed. IPG/bio.be was founded in 1958; founder names are not publicly known. Its business model centers on non-profit association.
IPG/bio.be has 1 tracked investment across 1 company. The latest tracked deal is $8.6M Other Equity in OncoDNA in September 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2016 | OncoDNA | $8.6M Other Equity | — | Crown Predator Holdings, Inventures, Invest4OncoDNA, Sambrinvest, Sofinim, Sriw, Vinsovier |